Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

Respiratory Medicine

Volumn 97, Issue 4, 2003, Pages 323-330

  Buhl, Roland ^a   Creemers, J P H M ^b   Vondra, V ^c   Martelli, N A ^d   Naya, I P ^e   Ekstrom T ^e  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b CATHARINA HOSPITAL   (Netherlands)

^c Soukroma Plicni Ambulance   (Czech Republic)

^d Neumonology Hospital   (Argentina)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; Budesonide; Formoterol; Once daily; Symbicort

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FORMOTEROL; TERBUTALINE;

ADULT; AROUSAL; ARTICLE; ASTHMA; BRONCHITIS; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HUMAN; INHALER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINITIS; RISK ASSESSMENT; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0037385766     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1427     Document Type: Article

References (25)

1. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219-224.
2. Woolcock AJ. The combined use of inhaled salmeterol and inhaled corticosteroids. Eur Respir Rev 1995; 5: 142-145.
3. Pauwels RA, Lofdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405-1411.
4. Horn CR, Clark TJH, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990; 84: 67-70.
5. Zetterström O, Buhl R, Mellem H, et al. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J 2001; 95: 1-7.
6. Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J. Onset of bronchodilation of budesonide/formoterol vs salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 2001; 14: 29-34.
7. Aziz I, Wilson AM, Lipworth BJ. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults. Chest 2000; 118: 1049-1058.
8. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: 5-40.
9. Rabe KF, Jörres R, Nowak D, Behr N, Magnussen H. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis 1993; 147: 1436-1441.
10. Ringdal N, Derom E, Wahlin-Boll E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler®. Respir Med 1998; 92: 1017-1021.
11. Palmqvist M, Persson G, Lazer L, Rosenborg J, Larsson P, Lötvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Respir J 1997; 10: 2484-2489.
12. Brusasco, V, Crimi E, Gherson G, Nardelle R, Oldani V, Fabbri L. Protective effect of formoterol against the late-phase asthmatic response to allergen. Eur Respir J 1997; 10: 474S.
13. Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982; 70: 288-298.
14. Malo JL, Cartier A, Merland N, et al. Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma. Am Rev Respir Dis 1989; 140: 624-628.
15. Venables TL, Addlestone MB, Smithers AJ, et al. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbuhaler and twice daily fluticasone propionate via a disc-inhaler at an equal dose of 400 μg in adult asthmatics, Br J Clin Res 1996; 7: 15-32.
16. Simons FE. Inhaled glucocorticoids in children: a favourable therapeutic index. Can Respir J 1999; 6: 175-178.
17. McFadden ER, Casale TB, Edwards TB, et al. Administration of budesonide once daily by means of Turbuhaler® to subjects with stable asthma. J Allergy Clin Immunol 1999; 104: 46-52.
18. Chisholm L, Dekker FW, Knuistingh Neven A, Petri H. Once-daily budesonide in mild asthma. Respir Med 1998; 92: 421-425.
19. Silkoff PE, Martin RJ. Pathophysiology of nocturnal asthma, Ann Allergy Asthma Immunol 1998; 81: 878-883.
20. Martin RJ. Small airway and alveolar tissue changes in nocturnal asthma. Am J Respir Crit Cure Med 1998; 157: S188-S190.
21. Jones AH, Langdon CG, Lee P, et al. PDI. Pulmicort® Turbuhaler® once daily as initial prophylactic therapy for asthma. Respir Med 1994; 88: 293-299.
22. Campbell LM, Gunn SD, Sweeney D, et al. Once daily budesonide: effective control of moderately severe asthma with 800 μg once daily inhaled via Turbuhaler when compared with 400 μg twice daily. Eur J Clin Res 1995; 7: 1-14.
23. Beam WR, Weiner DE, Martin RJ. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992; 146: 1524-1530.
24. Campbell LM, Gooding TN, Aitchison WR, Smith N, Powell JA. Initial loading (400 μg twice daily) versus static (400 μg nocte) dose budesonide for asthma management. PLAN Research Group. Int J Clin Pract 1998; 52: 361-370.
25. Chapman KR, Walker L, Cluley S, Fabbri L. Improving patient compliance with asthma therapy. Respir Med 2000; 94: 2-9.